Research / TPTS / Fundamental state Inspectable configuration
State dimensions Filing 0001674356-23-000024 Reit
Debt 86th Own-history percentile · N=14
Evidence method Level · gp.fundamentals.gross_debt
$439.6M · CORE · VALID
Revenue growth 70th Own-history percentile · N=10
Evidence method Yoy · gp.fundamentals.revenue
25.22% · CORE · VALID
Cash and equivalents 21th Own-history percentile · N=14
Evidence method Level · gp.fundamentals.cash
$19.2M · CORE · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 22 states Self-history eligible
Sep 30, 2021 0/6 normalized Level 3 Dec 31, 2021 0/6 normalized Level 3 Mar 31, 2022 2/5 normalized Level 3 Jun 30, 2022 2/5 normalized Level 3 Sep 30, 2022 2/4 normalized Level 3 Dec 31, 2022 2/5 normalized Level 3 Mar 31, 2023 4/5 normalized Level 3 Jun 30, 2023 4/6 normalized Level 3 Sep 30, 2023 3/3 normalized Level 3 Dec 31, 2023 5/5 normalized Level 3 Mar 31, 2024 5/6 normalized Level 3 Jun 30, 2024 4/4 normalized Level 3 Sep 30, 2024 3/3 normalized Level 3 Dec 31, 2024 4/4 normalized Level 3 Mar 31, 2025 4/4 normalized Level 3 Jun 30, 2025 4/4 normalized Level 3 Sep 30, 2025 5/5 normalized Level 3 Dec 31, 2025 4/4 normalized Level 3 Mar 31, 2026 5/5 normalized Level 3 Jun 30, 2026 4/4 normalized Level 4 Period transition
What moved in the state? Debt Decreased
Previous $467.0M
Current $439.6M
Delta -$27.4M Growth Decreased
Previous 27.88%
Current 25.22%
Delta -2.65% Liquidity Decreased
Previous $51.8M
Current $19.2M
Delta -$32.6M Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.